Skip to content

Determine if counselling patients on how to use Metered Dose Inhalers improves quality of life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69215680
Enrollment
120
Registered
2006-09-29
Start date
2005-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory: Asthma Respiratory Asthma

Interventions

Patients will have their inhalation technique assessed whilst inhaling from a placebo inhaler. Those with a good technique will be placed in the control group. Those with a poor technique will form t

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Asthma 2. Patients using at least one MDI without a spacer device Prescribed a preventer inhaler 3. Age 3-65 - Group 1: 3-6 years, Group 2: 7-17 years, Group 3: 16 to 65 years 4. Written signed consent

Exclusion criteria

Exclusion criteria: 1. Patients experiencing an acute exacerbation of asthma or receiving oral prednisolone in the four weeks prior to recruitment 2. Patients with other illnesses adversely affecting the respiratory system or evidence of fixed respiratory obstruction 3. Deaf or unable to distinguish between one and two tones with the Two-Tone trainer 4. Chronic obstructive pulmonary disease (COPD)

Design outcomes

Primary

MeasureTime frame
Changes in inspiratory flow rates through MDIs.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026